Invetx
William Brondyk is the Chief Scientific Officer at Invetx. His role is to develop and execute a research strategy to generate innovative and transformative biotherapeutics for the Animal Health market. William has more than 20 years of experience in developing protein therapeutics for oncology indications, immune-mediated diseases, infectious diseases, rare diseases, and reproductive health and contraception.
William received his Ph.D. in Oncology from the University of Wisconsin-Madison.
Invetx
At Invetx, they bring the best of biopharma to animal health. Their network includes experts in both animal and human health, veterinary scientists, and clinicians. Their vision is of a global animal health industry that fully leverages biopharma technologies to deliver dramatically improved health outcomes for pets and farm animal populations.